22.67

1.00% -0.23

After Hours: 22.51 -0.16 -0.71%

Schrodinger Inc (SDGR)

Overview News Price History Option Chain Financials Why SDGR Down? Discussions Forecast

Schrodinger Inc stock is traded at $22.67, with a volume of 616.32K. It is down -1.00% in the last 24 hours and down -12.84% over the past month. Schrodinger Inc is a healthcare-based software company. Its operating segments are Software and Drug discovery. Through the Software segment, the company is focused on selling software to transform drug discovery across the life sciences industry and customers in materials science industries. In the Drug discovery segment, it is engaged in generating revenue from a portfolio of preclinical and clinical programs, internally and through collaborations. It generates revenue from the sales of software solutions and from research funding and milestone payments from its drug discovery collaborations.

Previous Close:

$22.90

Open:

$23.03

24h Volume:

616.32K

Relative Volume:

0.70

Market Cap:

$1.66B

Revenue:

$193.35M

Net Income/Loss:

$-177.58M

P/E Ratio:

-9.2531

EPS:

-2.45

Net Cash Flow:

$-172.43M

1W Performance:

-0.44%

1M Performance:

-12.84%

6M Performance:

+8.78%

1Y Performance:

-12.94%

1-Day Range:

$22.66

$23.61

1-Week Range:

$21.52

$23.90

52-Week Range:

$16.67

$29.15

Schrodinger Inc Stock (SDGR) Company Profile

Name

Schrodinger Inc

Sector

Healthcare (1167)

Industry

Health Information Services (57)

Phone

503-299-1150

Address

1540 BROADWAY, NEW YORK, NY

Employee

787

Twitter

@schrodinger

Next Earnings Date

2024-11-12

Latest SEC Filings

SDGR's Discussions on Twitter

Compare SDGR with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
SDGR Schrodinger Inc	22.67	1.66B	193.35M	-177.58M	-172.43M	-2.45
VEEV Veeva Systems Inc	237.17	38.50B	2.75B	714.14M	1.09B	4.33
SOLV Solventum Corp	76.31	13.20B	8.26B	66.00M	1.17B	0.3682
DOCS Doximity Inc	62.69	11.76B	516.85M	174.11M	217.38M	0.87
TEM Tempus Ai Inc	48.03	8.27B	640.44M	-743.28M	-206.93M	-11.29
HQY Healthequity Inc	84.32	7.31B	1.15B	96.70M	-161.99M	1.09

Schrodinger Inc Stock (SDGR) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jul-02-24	Initiated	Leerink Partners	Outperform
Dec-05-23	Initiated	KeyBanc Capital Markets	Overweight
May-05-23	Resumed	Piper Sandler	Overweight
Dec-19-22	Initiated	Goldman	Neutral
Mar-01-22	Initiated	Citigroup	Buy
Nov-19-21	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Nov-19-21	Initiated	Piper Sandler	Overweight
Nov-11-21	Downgrade	BofA Securities	Buy → Neutral
Oct-13-21	Initiated	Berenberg	Buy
Sep-01-21	Upgrade	Morgan Stanley	Equal-Weight → Overweight
May-25-21	Initiated	Craig Hallum	Buy
Nov-23-20	Upgrade	BofA Securities	Neutral → Buy
Oct-12-20	Upgrade	Jefferies	Hold → Buy
Mar-02-20	Initiated	BMO Capital Markets	Outperform
Mar-02-20	Initiated	Jefferies	Hold
Mar-02-20	Initiated	Morgan Stanley	Equal-Weight

View All

Schrodinger Inc Stock (SDGR) Latest News

Mar 18, 2025

Schrodinger at KeyBanc Forum: Computational Drug Discovery Focus By Investing.com - Investing.com South Africa

Mar 18, 2025

Schrodinger at KeyBanc Forum: Computational Drug Discovery Focus - Investing.com India

Mar 18, 2025

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance

Mar 18, 2025

Mar 12, 2025

(SDGR) Proactive Strategies - Stock Traders Daily

Mar 12, 2025

Proficio Capital Partners LLC Purchases Shares of 11,285 Schrödinger, Inc. (NASDAQ:SDGR) - Defense World

Mar 12, 2025

Mar 10, 2025

Schrödinger adds Bridget van Kralingen to board By Investing.com - Investing.com Australia

Mar 10, 2025

Schrodinger at Leerink Global: Strategic Growth and Challenges - Investing.com India

Mar 10, 2025

Schrodinger appoints Bridget van Kralingen to board By Investing.com - Investing.com Canada

Mar 10, 2025

Schrödinger Expands Board of Directors with Appointment of Bridget van Kralingen - Bluefield Daily Telegraph

Mar 10, 2025

Mar 09, 2025